Hematology Today—June 2, 2026
This week’s Hematology update highlights ASCO 2026 readouts, regulatory…
Lucid Diligence Brief: SELLAS REGAL AML Phase 3 Nears Final Analysis
Lucid Diligence Brief: SELLAS approaches REGAL AML final analysis for…
Lucid Diligence Brief: Cullinan Therapeutics Gains FDA Orphan Drug Designation for CLN-049
Lucid Diligence Brief: Cullinan Therapeutics Receives FDA Orphan Drug…
Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML
Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML Professional…
Lucid Diligence Brief: Crossbow Therapeutics $77 million Series B for TCR-mimetics
Lucid Diligence Brief: Crossbow Therapeutics $77 million Series B for…
Lucid Diligence Brief: Amgen acquires Dark Blue Therapeutics
Lucid Diligence Brief: Amgen acquires Dark Blue Therapeutics Professional…
Hematology Today—November 3, 2025
Catch the latest hematology news, featuring industry updates, clinical…
Lucid Diligence Brief: Ipsen to acquire ImCheck Therapeutics
Lucid Diligence Brief: Ipsen to acquire ImCheck Therapeutics Professional…
AI in Healthcare and Digital Health Video Recap — October 20, 2025
This biweekly video summary highlights global updates in AI in Healthcare and…
Hematology Today: CAR-T, Gene Therapy and Radioconjugates (Oct 6–13, 2025)
This week’s hematology update highlights groundbreaking CAR-T and gene therapy…
Hematology Weekly News - October 6th 2025
Hematology Update: Cemsidomide–Elranatamab Combo, Ziftomenib AML Trial, Fast…
Hematology Weekly News - September 22nd 2025
Hematology Update: Inobrodib Trial, Tecvayli Combo, Bexobrutideg Data and……